The Effect of Comorbidities on the Choice of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia


SAYDAM G., ALİ R., DEMİR A. M., EŞKAZAN A. E., GÜVENÇ B., HAZNEDAROĞLU İ. C., ...Daha Fazla

International Journal of Hematologic Oncology, cilt.11, 2022 (ESCI)